期刊文献+

绝经后女性2型糖尿病合并冠心病的危险因素分析 被引量:7

Analysis of risk factors in type 2 diabetes mellitus combined with coro-nary heart disease in postmenopausal women
下载PDF
导出
摘要 目的 探讨绝经后女性2型糖尿病(T2DM)合并冠心病的主要相关危险因素。方法 选取2012年1月~2014年6月北京市大兴区红星医院内科住院的绝经后女性2型糖尿病患者335例,其中T2DM非合并冠心病组(无冠心病组)157例,T2DM合并冠心病组(冠心病组)178例。收集两组患者的临床资料;检测空腹血糖(FPG)、糖化血红蛋白(Hb A1c)、三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)及尿酸。结果 冠心病组年龄、糖尿病病程明显高于无冠心病组(P〈0.01);与无冠心病组比较,冠心病组的FPG、Hb A1c、体重指数、收缩压、TC、LDL-C及TG均升高,HDL-C降低(P〈0.05或P〈0.01);冠心病组的患者高血压、肥胖、血脂紊乱、颈动脉斑块及脑卒中发病率均高于无冠心病组,差异均有统计学意义(P〈0.05或P〈0.01);冠心病阳性家族史显著高于无冠心病组(P〈0.01)。Logistic回归分析结果显示,年龄、病程、Hb A1c、LDL-C及收缩压是T2DM合并冠心病的独立危险因素(OR值分别为1.21、1.08、1.49、1.11和1.03,P〈0.05或P〈0.01)。结论 年龄、糖尿病病程、Hb A1c、LDL-C及收缩压与绝经后女性2型糖尿病合并冠心病的发病密切相关。 Objective To investigate the related risk factors of type 2 diabetes mellitus (T2DM) combined with coronary heart disease (CHD) in postmenopausal women. Methods A total of 335 hospitalized postmenopansal women suffering from T2DM without CHD (non-CHD group, 157 cases) and with CHD (CHD group, 178 cases) were enrolled from Jan- uary 2012 to June 2014. Clinical data were collected and the levels of fasting plasma glucose (FPG), glycated hemoglobin (HbAlo), triglycerides (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C) and blood uric acid (UA) were detected. Results Compared with the non-CHD group,the CHD group showed significantly greater age and longer duration of diabetes (P 〈 0.01). Further, the CHD group had higher levels of fasting blood glucose, glycosylated hemoglobin, BMI, systolic blood pressure, TC, LDL-C and TG, and lower level of HDL-C (P 〈 0.05 or P 〈 0.01). The incidences of hypertension, obesity, dyslipidemia, carotid artery plaque, cerebral stroke of CHD group were all higher than those of non-CHD group, the differences were statistically signifi- cant (P 〈 0.05 or P 〈 0.01). Logistic analysis showed that, age, duration of diabetes mellitus, HbAlc, LDL-C, and sys- tolic blood pressure were the independent risk factors of T2DM combined with coronary heart disease (OR=1.21, 1.11, 1.49, 1.08 and 1.03; P 〈 0.05 or P 〈 0.01). Conclusion Age, duration of diabetes mellitus, HbAlc, LDL-C, and systolic blood pressure are closely related to the incidence of type 2 diabetes mellitus combined with coronary heart disease in postmenopausal women.
出处 《中国医药导报》 CAS 2015年第21期35-38,共4页 China Medical Herald
关键词 绝经后女性 2型糖尿病 冠心病 危险因素 Postmenopausal women Type 2 Diabetes meUitus Coronary heart disease Risk factor
  • 相关文献

参考文献19

二级参考文献255

共引文献12470

同被引文献71

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2117
  • 2Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) [J]. European heart journal, 2012,33 (13) : 1635-1701.
  • 3Ryden L,Grant PJ,Anker SD,et al. ESC Guidelines on diabetes,pre-diabetes and cardiovascular diseases devel- oped in collaboration with the EASD [J]. European heart journal, 2013,34(39) : 3035-3087.
  • 4Darlington A, Te!lo-Montoliu A, Rollini F, et al. Pharmac- odynamic effects of standard dose prasugrel versus high dose clopidogre! in non-diabetic obese patients with coronary artery disease [J]. Thromb Haemost, 2014,111 (2) : 258-265.
  • 5Angiolillo D J, Jakubowski JA, Ferreiro JL, et al. Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease [J]. Journal of the American College of Cardiology, 2014, 64 (10): 1005-1014.
  • 6Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease [J]. European heart journal, 2013,34 (38) : 2949 - 3003.
  • 7Roe MT,Armstrong PW,Fox KAA,et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascul- arization [J]. New England Journal of Medicine, 2012,367 (14) : 1297-1309.
  • 8Thukkani AK,Agrawal K,Prince L,et al. Long-term outcomes in patients with diabetes mellitus related to prolonging clopidogrel more than 12 months after coronary stenting [J]. Journal of the American College of Cardiology,2015,66 (10) : 1091-1101.
  • 9Andersson C,Lyngbaek S,Nguyen CD,et al. Association of clopidogrel treatment with risk of mortality and cardi- ovascular events following myocardial infarction in patients with and without diabetes [J]. JAMA,2012,308(9):882- 889.
  • 10Siller-Matula JM, Delle -Karth G, Christ G,et al. Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-re- sponsiveness to clopidogrel or aspirin [J]. International journal of cardiology, 2013,167 (2) : 430-435.

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部